United Therapeutics Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$783,300	$781,500	$790,200	$799,500
Gross Profit	683,800	648,100	686,800	698,600
EBITDA	375,600	343,900	469,900	462,900
EBIT		321,300	447,100	441,000
Net Income	333,000	274,900	364,300	338,700
Net Change In Cash	783,300	781,500	790,200	799,500
Free Cash Flow	205,600	362,500	173,300	351,600
Cash	1,803,200	1,074,200	1,557,100	1,136,600
Basic Shares	45,800	47,200	47,900	47,300

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,182,700	$2,877,400	$2,327,500	$1,936,300
Gross Profit	2,798,300	2,567,700	2,070,000	1,789,600
EBITDA	1,819,000	1,654,400	1,386,800	1,040,300
EBIT	1,733,400	1,581,900	1,333,600	989,000
Net Income	1,334,700	1,195,100	984,800	727,300
Net Change In Cash	3,182,700	2,877,400	2,327,500	1,936,300
Cost of Revenue				66,400
Free Cash Flow	1,040,700	1,080,600	747,600	663,700
Cash	1,557,100	1,697,200	1,207,700	961,200
Basic Shares	47,900	48,500	49,700	48,500